Oral Andro-Related Prohormone Supplementation: Do the Potential Risks Outweigh the Benefits?
- 1 February 2003
- journal article
- review article
- Published by Canadian Science Publishing in Canadian Journal of Applied Physiology
- Vol. 28 (1) , 102-116
- https://doi.org/10.1139/h03-009
Abstract
Androstenedione, 4-androstenediol, 5-androstenediol, 19-norandrostenediol and 19-norandrostenedione are commonly referred to as "Andro" prohormones. Over the last few years, supplementation using these prohormones has been aggressively marketed to the general public. Supplement manufacturers often claim that Andro use improves serum testosterone concentrations, increases muscular strength and muscle mass, helps to reduce body fatness, enhances mood, and improves sexual performance. However, to date, most studies contradict these claims. In contrast, several studies using oral Andro related prohormones show that Andro use can abnormally elevate estrogen related hormones as well as alterations in hormonal markers (i.e., abnormal elevations in serum estrogen) thought to increase a person's risk for developing prostate or pancreatic cancers. In addition, most studies also indicate that significant declines in high-density lipoproteins occur leading to an increased cardiovascular disease risk. Thus, to date, the current research base suggests that Andro prohormone use does not support manufacturer claims. But it does suggest there should be strong concerns regarding long-term oral Andro prohormone use, especially regarding its effects on blood lipids and estrogen hormone profiles. Key words: resistance exercise, androstenedione, androstenediol, anti-agingKeywords
This publication has 33 references indexed in Scilit:
- Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly menJournal of Clinical Investigation, 2000
- The Andro ProjectArchives of internal medicine (1960), 2000
- In vivo 4-androstene-3,17-dione and 4-androstene-3β,17β-diol supplementation in young menEuropean Journal of Applied Physiology, 2000
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- GynecomastiaNew England Journal of Medicine, 1993
- Pancreatic Cancer and Androgen MetabolismPancreas, 1990
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989
- Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletesThe American Journal of Sports Medicine, 1987
- Serum Lipids in Power Athletes Self-Administering Testosterone and Anabolic SteroidsInternational Journal of Sports Medicine, 1985
- Aromatization of Androstenedione to Estrone by Human Adipose Tissue in Vitro. Correlation with Adipose Tissue Mass, Age, and Endometrial Neoplasia*Journal of Clinical Endocrinology & Metabolism, 1981